Journal Mobile Options
Table of Contents
Vol. 34, No. 2, 2012
Issue release date: October 2012
Blood Purif 2012;34:194–199
(DOI:10.1159/000341721)

Prevention and Management of Dialysis Catheter Complications in the Intensive Care Unit

Wilson P. · Lertdumrongluk P. · Leray-Moragués H. · Chenine-Koualef L. · Patrier L. · Canaud B.
Nephrology, Dialysis and Intensive Care, Lapeyronie University Hospital – CHU Montpellier, Montpellier, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Dialysis dependence at hospital discharge after acute kidney injury (AKI) requiring renal replacement therapy (RRT) in the intensive care unit (ICU) is found in 10–15% of survivors. In case of severe AKI in the ICU, it is necessary to reconcile two objectives: the creation of an adequate temporary angioaccess for RRT and the preservation of the patient’s vascular network in case of evolution to end-stage renal disease. A central venous catheter (CVC) is the best option for RRT in the ICU setting. Most catheter-related hazards can be prevented by following best clinical practices for insertion and handling of the CVC, and by knowing the advantages and disadvantages of the different types of catheters, the sites and techniques of insertion, the types of RRT modality for choosing the best CVC option, and the prophylactic and therapeutic measures to prevent and to manage the complications. We review here some important aspects of the CVC for the treatment of AKI in the ICU.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813–818.
  2. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009;24:129–140.
  3. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, Bagshaw SM: A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011;15:R72.
  4. Van Waeleghem JP: Vascular access in acute renal failure. EDTNA ERCA J 2002;(suppl 2):23–25, 29.
  5. Jan Tordoir, Bernard Canaud, Patrick Haage, Klaus Konner, Ali Basci, Denis Fouque, Jeroen Kooman, Alejandro Martin-Malo, Luciano Pedrini, Francesco Pizzarelli, James Tattersall, Marianne Vennegoor, Christoph Wanner, Piet ter Wee, Raymond Vanholder: EBPG on vascular access. Nephrol Dial Transplant 2007;22(suppl 2):88–117.

    External Resources

  6. Oliver MJ: Acute dialysis catheters. Semin Dial 2001;14:432–435.
  7. Canaud B, Desmeules S, Klouche K, Leray-Moragués H, Béraud JJ: Vascular access for dialysis in the intensive care unit. Best Pract Res Clin Anaesthesiol 2004;18:159–174.
  8. Brown JM: Polyurethane and silicone: myths and misconceptions. J Intraven Nurs 1995;18:120–122.
  9. Schummer W, Sakr Y, Schummer C: Towards optimal central venous catheter tip position; in Vincent J-L (ed): Intensive Care Medicine. Berlin, Springer, 2008, pp 581–590.
  10. Vesely TM: Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol 2003;14:527–534.
  11. Davenport A: Dialytic treatment for septic patients with acute kidney injury. Kidney Blood Press Res 2011;34:218–224.
  12. Parienti JJ, Thirion M, Megarbane B, et al: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008;299:2413–2422.
  13. Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group: Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Crit Care Med 2012;40:420–429.

    External Resources

  14. MacRae JM, Ahmed A, Johnson N, Levin A, Kiaii M: Central vein stenosis: a common problem in patients on hemodialysis. ASAIO J 2005;51:77–81.
  15. Agarwal AK, Patel BM, Haddad NJ: Central vein stenosis: a nephrologist’s perspective. Semin Dial 2007;20:53–62.

    External Resources

  16. Klouche K, Amigues L, Deleuze S, et al: Complications, effects on dialysis dose, and survival of tunnelled femoral dialysis catheters in acute renal failure. Am J Kidney Dis 2007;49:99–108.
  17. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C: Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998;26:1452–1457.
  18. Vats HS: Complications of catheters: tunneled and nontunneled. Adv Chronic Kidney Dis 2012;19:188–194.

    External Resources

  19. Leblanc M, Bosc JY, Paganini EP, Canaud B: Central venous dialysis catheter dysfunction. Adv Ren Replace Ther 1997;4:377–389.
  20. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Di 2006;48(suppl 1):S176–S247.
  21. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.
  22. Willms L, Vercaigne LM: Does warfarin safely prevent clotting of hemodialysis catheters? A review of efficacy and safety. Semin Dial 2008;21:71–77.
  23. Colì L, Donati G, Cianciolo G, Raimondi C, Comai G, Panicali L, Nastasi V, Cannarile DC, Gozzetti F, Piccari M, Stefoni S: Anticoagulation therapy for the prevention of hemodialysis tunnelled cuffed catheters (TCC) thrombosis. J Vasc Access 2006;7:118–122.
  24. Atapour A, Mosakazemi M, Mortazavi M, Beigi A, Shahidi S: Access recirculation in jugular venous catheter in regular and reversed lines. Iran J Kidney Dis 2008;2:91–94.
  25. Moossavi S, Vachharajani TJ, Jordan J, Russell GB, Kaufman T, Moossavi S: Retrospective analysis of catheter recirculation in prevalent dialysis patients. Semin Dial 2008;21:289–292.

    External Resources

  26. Fong IW: Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J 1993;69(suppl 3):S15–S17.

    External Resources

  27. Moran JE, Ash SR: Locking solutions for hemodialysis catheters; heparin and citrate – a position paper by ASDIN. Semin Dial 2008;21:490–492.
  28. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39(4 suppl 1):S1–S34.

    External Resources

  29. Timsit JF: Scheduled replacement of central venous catheters is not necessary. Infect Control Hosp Epidemiol 2000;21:371–374.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50